Cardiovascular risk factors, radiation therapy, and myocardial infarction among lymphoma survivors

References

• Andre M, Mounier N, Leleu X, et al. Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients. Blood. 2003;103(4):1222–1228.
   PubMed Web of Science ®Google Scholar
• Moser EC, Noordijk EM, van Leeuwen FE, et al. Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma. Blood. 2006;107(7):2912–2919.
   PubMed Web of Science ®Google Scholar
• Salz T, Zabor EC, de Nully Brown P, et al. Preexisting cardiovascular risk and subsequent heart failure among non-Hodgkin lymphoma survivors. J Clin Oncol. 2017;35(34):3837–3843.
   PubMed Web of Science ®Google Scholar
• Kamel MG, El-Qushayri AE, Thach TQ, et al. Cardiovascular mortality trends in non-Hodgkin's lymphoma: a population-based cohort study. Expert Rev Anticancer Ther. 2018;18(1):91–100.
   PubMed Web of Science ®Google Scholar
• Abuamsha H, Kadri AN, Hernandez AV. Cardiovascular mortality among patients with non-Hodgkin lymphoma: differences according to lymphoma subtype. Hematol Oncol. 2019;37(3):261–269.
   PubMed Web of Science ®Google Scholar
• Zhao J, Su L, Zhong J. Risk factors for cancer-specific mortality and cardiovascular mortality in patients with diffuse large B-cell lymphoma. Clin Lymphoma Myeloma Leuk. 2020;20(11):e858–e863.
   PubMed Web of Science ®Google Scholar
• Thanarajasingam G, Minasian LM, Baron F, et al. Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies. Lancet Haematol. 2018;5(11):e563–e598.
   PubMed Web of Science ®Google Scholar
• Jaworski C, Mariani JA, Wheeler G, et al. Cardiac complications of thoracic irradiation. J Am Coll Cardiol. 2013;61(23):2319–2328.
   PubMed Web of Science ®Google Scholar
• Gaya AM, Ashford RF. Cardiac complications of radiation therapy. Clin Oncol. 2005;17(3):153–159.
   Web of Science ®Google Scholar
• Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987–998.
   PubMed Web of Science ®Google Scholar
• Boyne DJ, Mickle AT, Brenner DR, et al. Long-term risk of cardiovascular mortality in lymphoma survivors: a systematic review and meta-analysis. Cancer Med. 2018;7(9):4801–4813.
   PubMed Web of Science ®Google Scholar
• Vallerio P, Maloberti A, Palazzini M, et al. Thoracic radiotherapy as a risk factor for heart ischemia in subjects treated with chest irradiation and chemotherapy and without classic cardiovascular RISK factors. Radiother Oncol. 2020;152:146–150.
   PubMed Web of Science ®Google Scholar
• Heidenreich PA, Hancock SL, Lee BK, et al. Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol. 2003;42(4):743–749.
   PubMed Web of Science ®Google Scholar
• Armenian SH, Xu L, Ky B, et al. Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study. J Clin Oncol. 2016;34(10):1122–1130.
   PubMed Web of Science ®Google Scholar
• Armstrong GT, Oeffinger KC, Chen Y, et al. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J Clin Oncol. 2013;31(29):3673–3680.
   PubMed Web of Science ®Google Scholar
• Pedersen CB. The Danish Civil Registration System. Scand J Public Health. 2011;39(7 Suppl):22–25.
   PubMed Web of Science ®Google Scholar
• Helweg-Larsen K. The Danish Register of causes of death. Scand J Public Health. 2011;39(7 Suppl):26–29.
   PubMed Web of Science ®Google Scholar
• Arboe B, El-Galaly TC, Clausen MR, et al. The Danish National Lymphoma Registry: coverage and data quality. PLOS One. 2016;11(6):e0157999.
   PubMed Web of Science ®Google Scholar
• Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39(7 Suppl):30–33.
   PubMed Web of Science ®Google Scholar
• Dalton SO, Steding-Jessen M, Gislum M, et al. Social inequality and incidence of and survival from cancer in a population-based study in Denmark, 1994–2003: background, aims, material and methods. Eur J Cancer. 2008;44(14):1938–1949.
   PubMed Web of Science ®Google Scholar
• Kildemoes HW, Sorensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39(7 Suppl):38–41.
   PubMed Web of Science ®Google Scholar
• Ng AK. Review of the cardiac long-term effects of therapy for Hodgkin lymphoma. Br J Haematol. 2011;154:23–31.
   PubMed Web of Science ®Google Scholar
• Reinders JG, Heijmen BJ, Olofsen-van Acht MJ, et al. Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up. Radiother Oncol. 1999;51(1):35–42.
   PubMed Web of Science ®Google Scholar
• Hancock SL, Tucker MA, Hoppe RT. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA. 1993;270(16):1949–1955
   PubMed Web of Science ®Google Scholar
• Adams MJ, Lipsitz SR, Colan SD, et al. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol. 2004;22(15):3139–3148.
   PubMed Web of Science ®Google Scholar
• Hoppe RT, Advani RH, Ai WZ, et al. Hodgkin lymphoma version 1.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2017;15(5):608–638.
   PubMed Web of Science ®Google Scholar
• Curigliano G, Cardinale D, Suter T, ESMO Guidelines Working Group, et al. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO clinical practice guidelines. Ann Oncol. 2012;23(Suppl 7):vii155–66.
   PubMed Web of Science ®Google Scholar
• Hoppe BS, Bates JE, Mendenhall NP, et al. The meaningless meaning of mean heart dose in mediastinal lymphoma in the modern radiation therapy era. Pract Radiat Oncol. 2020;10(3):e147–e154.
   PubMed Web of Science ®Google Scholar
• Levis M, Filippi AR, Fiandra C, et al. Inclusion of heart substructures in the optimization process of volumetric modulated arc therapy techniques may reduce the risk of heart disease in Hodgkin's lymphoma patients. Radiother Oncol. 2019;138:52–58.
   PubMed Web of Science ®Google Scholar
• Lundgaard AY, Hjalgrim LL, Dejanovic D, et al. Relapse localization in Danish pediatric patients with hodgkin lymphoma. Acta Oncol. 2021;60(5):658–666.
   PubMed Web of Science ®Google Scholar
• Gillespie EF, Rodin D. Should We contour cardiac substructures in routine practice? How autosegmentation helped us get there (or not). Int J Radiat Oncol Biol Phys. 2022;112(3):633–635.
   PubMed Web of Science ®Google Scholar